In a separate study, a patient with refractory HCC carrying an FANCA germline variant, having previously undergone multiple therapies, was treated with olaparib and cisplatin, resulting in progression-free survival for 12 months.111. The gene discussed is FANCA; the disease is hepatocellular carcinoma.